跳至主要内容
临床试验/ACTRN12624000786594
ACTRN12624000786594尚未招募Unknown

Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – the ERADICATE study: a phase II randomised controlled trial

Edith Cowan University0 个研究点目标入组 50 人开始时间: 2024年6月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • I) Patients diagnosed with localised or locally advanced prostate cancer;
  • II) Patients scheduled for conventional or moderately hypofractionated external beam radiotherapy; and
  • III) Approval from treating oncologist to participate in study.

排除标准

  • I) Previous radical prostatectomy;
  • II) Patients already engaging in regular exercise (defined as undertaking structured, i.e. planned and individualised, aerobic or resistance exercise on 2 or more days per week within the past 3 months);
  • III) Acute illness or musculoskeletal/ cardiovascular/ neurological disorder that could put patients at risk during exercise testing or training;
  • IV) Bone metastases; and
  • V) Contraindication to magnetic resonance imaging.

研究者

相似试验